DISHMAN CARBOGEN AMCIS
|
|
BOM : 540701     NSE : DCAL     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Mild Upward Pledged Shares : None or < 25% |
Jun 24,2022 |
Price(EOD): ₹ 114.15
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 1,789.87 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
DISHMAN CARBOGEN AMCIS | 10.9% | 1.9% | -45.9% |
SUN PHARMACEUTICAL INDUSTRIES | 2.4% | -8.5% | 23.8% |
DIVIS LABORATORIES | 4.3% | 6.7% | -12.6% |
DR REDDYS LABORATORIES | 3.8% | 0% | -18.7% |
CIPLA | 0.8% | -3.2% | -2.4% |
GLAND PHARMA | 2.4% | -7.3% | -17.9% |
PIRAMAL ENTERPRISES | 3.9% | -11% | -33.4% |
CADILA HEALTHCARE | 5.7% | -5.1% | -45.1% |
TORRENT PHARMACEUTICALS | 4.1% | -0.9% | -2.5% |
FUNDAMENTAL ANALYSIS OF DISHMAN CARBOGEN AMCIS
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF DISHMAN CARBOGEN AMCIS
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
-
P/E Calculated based on EPS of -10.53
[ Mar2021 - Consolidated Results ] 0.31
P/B Calculated based on Book Value of 363.45
[ Mar2021 - Consolidated Results ] 0.84
P/S Calculated based on Revenues of 2140.7 Cr
[ TTM - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
138% -6% -36% |
SHARE PRICE MOMENTUM OF DISHMAN CARBOGEN AMCIS
DISHMAN CARBOGEN AMCIS vs SENSEX
DEBT OF DISHMAN CARBOGEN AMCIS
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2021 2020 2019 Avg_3yrs |
0.11 0.12 0.12 0.12 |
0.2 0.18 0.19 0.19 |
[Last Annual Data : Mar2021]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF DISHMAN CARBOGEN AMCIS
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Mar2022 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF DISHMAN CARBOGEN AMCIS
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
1.23% -79.92% -321.67% -226.12% |
7.49% -75.11% -518.56% 66.95% |
QtrlyTrend |
-2 | |
Latest Qtr: Mar2022 | ||
Quarterly Result Analysis → |
DISHMAN CARBOGEN AMCIS related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE HEALTHCARE | 3.1% | -1.8% | -13% |
S&P BSE ALLCAP | 2.5% | -2% | -0.8% |
S&P BSE MIDSMALLCAP | 2% | -1.4% | -2% |
S&P BSE SMALL CAP | 1.6% | -2.4% | -1.3% |
You may also like the below Video Courses
FAQ about DISHMAN CARBOGEN AMCIS
Is DISHMAN CARBOGEN AMCIS good for long term investment?
As on Jun 24,2022, the Fundamentals of DISHMAN CARBOGEN AMCIS look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of DISHMAN CARBOGEN AMCIS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is DISHMAN CARBOGEN AMCIS UnderValued or OverValued?
As on Jun 24,2022, DISHMAN CARBOGEN AMCIS is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of DISHMAN CARBOGEN AMCIS ?
As on Jun 24,2022, the Intrinsic Value of DISHMAN CARBOGEN AMCIS is Rs. 121.14 determined based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 47.87
Fair Value [Median EV / Sales Model] : Rs. 121.14
Fair Value [Median Price / Sales Model] : Rs. 179.60
Median Fair Value of DISHMAN CARBOGEN AMCIS : Rs. 121.14
Is DISHMAN CARBOGEN AMCIS trading at a Premium or Discount?
As on Jun 24,2022, DISHMAN CARBOGEN AMCIS is trading at a Discount of -6% based on the estimates of Median Intrinsic Value!SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
